Abstract
Healthcare systems in emerging economies often operate under persistent resource constraints, high demand variability, and infrastructure limitations that shape how medicines, diagnostics, vaccines, and consumables reach patients. Supply chains therefore act as a practical interface between financing, physical distribution, and clinical service delivery, with performance expressed not only in budget execution but also in stock availability, travel burden, and timeliness of care. This paper analyzes the efficiency and resilience of healthcare supply chains in emerging economies by integrating cost structures, accessibility, and service delivery outcomes within a unified analytical perspective. The discussion distinguishes procurement, transportation, inventory holding, cold-chain compliance, wastage, and administrative overhead, and it highlights how fragmented governance and heterogeneous provider mixes alter the marginal costs of reliability. Accessibility is examined through spatial and temporal dimensions, including facility catchments, last-mile constraints, and the interaction between stockouts and patient travel behavior. Resilience is treated as the ability to sustain essential product availability under disruptions such as supplier failures, port delays, currency shocks, and localized transport outages, with emphasis on trade-offs between redundancy and operating efficiency. A mathematical framework is presented to formalize multi-echelon flows, risk exposure, and service-level guarantees under uncertainty. The paper then links supply chain performance to service delivery outcomes by considering how availability, lead times, and product quality propagate into treatment initiation, continuity, and effective coverage. The analysis is intended to support structured reasoning about design and policy choices under realistic constraints rather than to promote a single optimal model.
References

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2026 author
